ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pfizer and the National Comprehensive Cancer Network, an alliance of 23 U.S. cancer centers, will establish a peer-reviewed grant program for projects targeting health care quality improvements and health care provider education. The partners say they plan to issue a request for proposals for projects focused on evidence-based initiatives to improve patient care and outcomes in renal cell carcinoma and hematological malignancies. NCCN’s Oncology Research Program will be the lead organization for review and evaluation of applications.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X